.The Zeeuws Investment Fund invests in Eaglet Eye; a company that develops high-tech instruments for eye care professionals. The investment of the ZIF will mainly be used for the international launch of the ESP.
The ESP is a revolutionary precision instrument for the measurement of the eye, and of essential importance for the safe and comfortable fit of contact lenses, special contact lenses in particular. The ESP is the first device that is able to measure a diameter of 20mm of the eye surface. The technology was originally developed at the University of Maastricht and has seen continued development by parties in the Netherlands in cooperation with international experts in the optometry field.
Eaglet Eye CEO, Arnoud Snepvangers: “With the Zeeuws Investment Fund, we feel we have chosen the right investor to not only support us with their capital, but also with their knowledge and expertise. This allows our company to grow internationally and to realize the ambition to improve the quality of vision around the world, both for the patient and the ophthalmologist.”
Johan Sebregts, director of the Zeeuws Investment Fund: “Eaglet Eye fits very well into the ZIF portfolio. Eaglet Eye brings new and inspiring technology on the market and has the potential to become a global player in the field of precision instruments for eye care. We foresee a bright future for Eaglet Eye.”
More information about Eaglet Eye.
The ESP is a revolutionary precision instrument for the measurement of the eye, and of essential importance for the safe and comfortable fit of contact lenses, special contact lenses in particular. The ESP is the first device that is able to measure a diameter of 20mm of the eye surface. The technology was originally developed at the University of Maastricht and has seen continued development by parties in the Netherlands in cooperation with international experts in the optometry field.
Eaglet Eye CEO, Arnoud Snepvangers: “With the Zeeuws Investment Fund, we feel we have chosen the right investor to not only support us with their capital, but also with their knowledge and expertise. This allows our company to grow internationally and to realize the ambition to improve the quality of vision around the world, both for the patient and the ophthalmologist.”
Johan Sebregts, director of the Zeeuws Investment Fund: “Eaglet Eye fits very well into the ZIF portfolio. Eaglet Eye brings new and inspiring technology on the market and has the potential to become a global player in the field of precision instruments for eye care. We foresee a bright future for Eaglet Eye.”
More information about Eaglet Eye.
